Welcome to Novo Nordisk in the United States
 ...

Everyone has been affected by COVID-19 in some way, and we especially recognize the concerns and challenges that this serious health crisis continues to bring. As we continue to navigate through the COVID-19 pandemic and eventually transition to the post-COVID environment ahead, Novo Nordisk continues to remain focused on three key priorities:
 

  • Ensuring patients continue to get the medicines they need
  • Keeping our employees safe
  • Supporting the public health agenda
     

You can find some information about all this here. And, depending on what information you need, contact us at the numbers and websites below. We’re here to help.

For general inquiries: 1.800.727.6500
 

For our Diabetes Patient Assistance Program, affordability and NovoCare services: 1.844.NOVO4ME (844.668.6463) or visit NovoCare.com
 

For Rare Bleeding Disorder services, please visit NovoSecure.com
 

If you’re a healthcare professional: NovoMedLink is your source for diabetes product samples and support during the Coronavirus outbreak. For growth hormone, please contact your local representative.
 

 


covid-flu

 

If you’re living with diabetes or obesity, having the flu before or at the same time as COVID-19 can lead to worse outcomes. The CDC recommends people 6 months +  get a flu vaccine. 


Additional Resources

For up-to-date information and updates about the novel coronavirus (COVID-19), Consumers and healthcare professionals can visit the Centers for Disease Control and Prevention (CDC) and the websites of your state’s health department. Disease-specific resources to help you manage through the pandemic can be found below. If you’re a patient with concerns or questions, please contact your physician or healthcare provider.

Enhanced Patient Assistance Program

Enhanced patient assistance program

People with diabetes facing financial difficulties as a result of the COVID-19 pandemic can access a free 90-day supply of insulin under Novo Nordisk Inc.’s newly enhanced Patient Assistance Program (PAP). If you’re experiencing job loss, termination of healthcare benefits, or COBRA extension due to the pandemic, you may be eligible.

For more information, read our press release.

View a video message from Doug Langa, Executive Vice President, North America Operations and President of Novo Nordisk Inc. about how we're helping the patients and healthcare professionals looking to us for help during the pandemic. 


Availability of medicines

We have ample supplies of medicines, including insulin, and we expect to be able to fulfill orders and replenish pharmacies in the US throughout this pandemic. Because of periodic increases in demand, there may be times when local pharmacies are temporarily out of stock of diabetes medicines. We are working with our distributors to ensure that there is enough inventory to fill prescriptions quickly.


Keeping our employees safe

Keeping our employees safe

We are continuing to provide our family of over 5,000 employees with information, resources and expanded benefits to support them during the COVID-19 pandemic. Importantly, serving patients means that our employees have to be available and healthy to ensure our continued operations, regardless of their locations in offices, laboratories, on production lines or as representatives out in the community calling on customers.  

At our manufacturing facilities, we have implemented procedures to support the health and safety of our essential employees so they can continue production of our medicines 24/7 throughout the pandemic.


Supporting local relief efforts

We remain committed to doing our part for the communities we serve. We’ve provided more than a million dollars in monetary and in kind donations to national relief organizations, as well as to New York City/New Jersey/Philadelphia relief efforts, including Direct Relief, AmeriCares, the NYC Emergency COVID-19 Relief Fund, the New Jersey Pandemic Relief Fund and the Philadelphia COVID-19 Relief Fund. Our relief efforts also include:

  • Continuing to partner with more regional and national organizations to help support local families with their basic needs, including the Partnership for Healthier America’s Fresh Food Fund that provided Denver families with 600,000 servings of fresh fruit and vegetables that might have otherwise gone to waste.
  • Donating PPE whenever we can. While many of our workers at our manufacturing facilities need this equipment to be able to safely produce medicines, we’re continuing to donate supplies to local health systems in New Jersey and North Carolina.
  • Supporting employees who are safely volunteering to help those in need in their own communities. Employees are supporting food banks and community food distribution programs, including some taking place in our New Jersey home office parking lot this summer that helped more than 1,500 local families in need of fresh, healthy food. Other employees are making masks and shopping for and donating school supplies.

Living with diabetes during COVID-19

Living with diabetes during
COVID-19

Novo Nordisk CMO Dr. Todd Hobbs answers questions about managing your health as the pandemic continues.

View the video series

 


Commonly Asked Questions